Johnson And Johnson (JNJ) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Johnson and Johnson  (NYSE: JNJ)
 

Johnson And Johnson Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Johnson And Johnson's Inventory turnover ratio has remained unchanged compare to previous quarter at 2.17 in the third quarter 2026Average processing period, for Johnson And Johnson's inventories remained unchanged at 168 days, in the Sep 27 2026 quarter.

Within Healthcare sector 181 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2026, to 1521, from total ranking in the second quarter 2026 at 1695.

JNJ Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Johnson And Johnson Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

JNJ Inventory Turnover Ratio (Sep 27 2026)
III. Quarter		 (Jun 28 2026)
II. Quarter		 (Mar 29 2026)
I. Quarter		 (Dec 28 2025)
IV. Quarter		 (Sep 28 2025)
III. Quarter
Y / Y Inventory Growth 8.7 % 12.91 % 15.2 % 14.04 % 12.24 %
Y / Y Cost of Sales Growth 10.87 % 5.55 % 10.18 % 11.78 % 4.88 %
Inventory Turnover Ratio (TTM) 2.17 2.17 2.2 2.22 2.23
JNJ's Total Ranking # 1521 # 1695 # 1523 # 1512 # 1526
Average inventory processing period 168 169 166 164 163
Seq. Inventory Growth 1.54 % 3.85 % 2.76 % 0.32 % 5.47 %
Seq. Cost of Sales Growth 0.57 % -0.68 % 1.73 % 9.11 % -4.26 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 51
Healthcare Sector # 182
Overall Market # 1521

Inventory Turnover Ratio Statistics
High Average Low
3.64 2.89 2.05
(Sep. 30, 2010)   (March 31, 2014)



JNJ Company Profile >> Back to JNJ Efficiency Comparisons >> Compare JNJ Inventory Turnover Ratio to its Competitors

Financial Statements
Johnson And Johnson's Inventories $ 15,377 Millions Visit JNJ's Balance sheet
Johnson And Johnson's Cost of Revenues TTM $ 32,222 Millions Visit JNJ's Income Statement
What are JNJ's Sales? Visit JNJ's Sales by Segment

Other Inventory Turnover Ratios
Johnson And Johnson's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
JNJ's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for JNJ's Competitors
Inventory Turnover Ratio for JNJ's Suppliers
Inventory Turnover Ratio for JNJ's Customers

You may also want to know
JNJ's Sales Growth Rates JNJ's Pe Price to earnings ratio JNJ's Receivables Turnover Ratio JNJ's Stock Quote
JNJ's Net Income Growth Rates JNJ's Ps Price to Sales ratio JNJ's Sales per Employee JNJ's Asset Turnover Ratio
JNJ's Net Margin JNJ's Pb Price to Book ratio JNJ's Financial Strength Ratios JNJ's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 27 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 27 2026 Inventories at quarter ending Sep 27 2026
Transmedics Group Inc   5.70 $ 301.220  Millions$ 53  Millions
Bristol myers Squibb Company  5.65 $ 15,389.000  Millions$ 2,722  Millions
Avantor Inc   5.48 $ 4,539.200  Millions$ 828  Millions
Tactile Systems Technology Inc   5.25 $ 82.718  Millions$ 16  Millions
Integer Holdings Corporation  4.98 $ 1,376.268  Millions$ 276  Millions
Ge Healthcare Technologies Inc   4.69 $ 11,372.000  Millions$ 2,425  Millions
West Pharmaceutical Services Inc   4.69 $ 2,120.200  Millions$ 452  Millions
Henry Schein Inc   4.63 $ 9,395.000  Millions$ 2,031  Millions
Cryoport inc   4.60 $ 102.157  Millions$ 22  Millions
Myomo Inc   4.58 $ 14.802  Millions$ 3  Millions
Idexx Laboratories Inc  4.52 $ 1,743.379  Millions$ 386  Millions
Autolus Therapeutics Plc  4.34 $ 88.293  Millions$ 20  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
Electromed Inc   4.18 $ 14.878  Millions$ 4  Millions
Intelligent Bio Solutions Inc   4.14 $ 2.206  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Sonoma Pharmaceuticals Inc   3.90 $ 14.275  Millions$ 4  Millions
Koru Medical Systems Inc   3.88 $ 16.831  Millions$ 4  Millions
Incyte Corporation  3.79 $ 439.399  Millions$ 116  Millions
Baxter International Inc   3.57 $ 8,117.000  Millions$ 2,277  Millions
Bausch Health Companies Inc   3.54 $ 4,518.000  Millions$ 1,276  Millions
Coherus Oncology inc   3.50 $ 16.193  Millions$ 5  Millions
Exelixis Inc   3.49 $ 93.324  Millions$ 27  Millions
Abbvie Inc   3.40 $ 17,346.000  Millions$ 5,108  Millions
Gilead Sciences Inc   3.30 $ 6,219.000  Millions$ 1,884  Millions
Iovance Biotherapeutics inc   3.21 $ 177.232  Millions$ 55  Millions
Teva Pharmaceutical Industries Limited  3.16 $ 8,011.000  Millions$ 2,537  Millions
Msa Safety Inc  3.00 $ 1,063.235  Millions$ 354  Millions
Mimedx Group Inc   2.98 $ 70.562  Millions$ 24  Millions

Date modified: 2026-10-22T05:13:24+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.